Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://phoebedjxm965630.ampedpages.com/trelaglutide-exploring-a-new-option-for-chronic-diseases-65915546